Cargando…

Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles

The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antige...

Descripción completa

Detalles Bibliográficos
Autores principales: Brouwer, Philip J. M., Antanasijevic, Aleksandar, de Gast, Marlon, Allen, Joel D., Bijl, Tom P. L., Yasmeen, Anila, Ravichandran, Rashmi, Burger, Judith A., Ozorowski, Gabriel, Torres, Jonathan L., LaBranche, Celia, Montefiori, David C., Ringe, Rajesh P., van Gils, Marit J., Moore, John P., Klasse, Per Johan, Crispin, Max, King, Neil P., Ward, Andrew B., Sanders, Rogier W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873233/
https://www.ncbi.nlm.nih.gov/pubmed/33563983
http://dx.doi.org/10.1038/s41541-021-00285-9
_version_ 1783649343153111040
author Brouwer, Philip J. M.
Antanasijevic, Aleksandar
de Gast, Marlon
Allen, Joel D.
Bijl, Tom P. L.
Yasmeen, Anila
Ravichandran, Rashmi
Burger, Judith A.
Ozorowski, Gabriel
Torres, Jonathan L.
LaBranche, Celia
Montefiori, David C.
Ringe, Rajesh P.
van Gils, Marit J.
Moore, John P.
Klasse, Per Johan
Crispin, Max
King, Neil P.
Ward, Andrew B.
Sanders, Rogier W.
author_facet Brouwer, Philip J. M.
Antanasijevic, Aleksandar
de Gast, Marlon
Allen, Joel D.
Bijl, Tom P. L.
Yasmeen, Anila
Ravichandran, Rashmi
Burger, Judith A.
Ozorowski, Gabriel
Torres, Jonathan L.
LaBranche, Celia
Montefiori, David C.
Ringe, Rajesh P.
van Gils, Marit J.
Moore, John P.
Klasse, Per Johan
Crispin, Max
King, Neil P.
Ward, Andrew B.
Sanders, Rogier W.
author_sort Brouwer, Philip J. M.
collection PubMed
description The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.
format Online
Article
Text
id pubmed-7873233
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-78732332021-02-16 Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles Brouwer, Philip J. M. Antanasijevic, Aleksandar de Gast, Marlon Allen, Joel D. Bijl, Tom P. L. Yasmeen, Anila Ravichandran, Rashmi Burger, Judith A. Ozorowski, Gabriel Torres, Jonathan L. LaBranche, Celia Montefiori, David C. Ringe, Rajesh P. van Gils, Marit J. Moore, John P. Klasse, Per Johan Crispin, Max King, Neil P. Ward, Andrew B. Sanders, Rogier W. NPJ Vaccines Article The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes. Nature Publishing Group UK 2021-02-09 /pmc/articles/PMC7873233/ /pubmed/33563983 http://dx.doi.org/10.1038/s41541-021-00285-9 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Brouwer, Philip J. M.
Antanasijevic, Aleksandar
de Gast, Marlon
Allen, Joel D.
Bijl, Tom P. L.
Yasmeen, Anila
Ravichandran, Rashmi
Burger, Judith A.
Ozorowski, Gabriel
Torres, Jonathan L.
LaBranche, Celia
Montefiori, David C.
Ringe, Rajesh P.
van Gils, Marit J.
Moore, John P.
Klasse, Per Johan
Crispin, Max
King, Neil P.
Ward, Andrew B.
Sanders, Rogier W.
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_full Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_fullStr Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_full_unstemmed Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_short Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
title_sort immunofocusing and enhancing autologous tier-2 hiv-1 neutralization by displaying env trimers on two-component protein nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873233/
https://www.ncbi.nlm.nih.gov/pubmed/33563983
http://dx.doi.org/10.1038/s41541-021-00285-9
work_keys_str_mv AT brouwerphilipjm immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT antanasijevicaleksandar immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT degastmarlon immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT allenjoeld immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT bijltompl immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT yasmeenanila immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT ravichandranrashmi immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT burgerjuditha immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT ozorowskigabriel immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT torresjonathanl immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT labranchecelia immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT montefioridavidc immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT ringerajeshp immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT vangilsmaritj immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT moorejohnp immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT klasseperjohan immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT crispinmax immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT kingneilp immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT wardandrewb immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles
AT sandersrogierw immunofocusingandenhancingautologoustier2hiv1neutralizationbydisplayingenvtrimersontwocomponentproteinnanoparticles